Press Archives | Page 8 of 18

CureMatch Hires CFO, Katie Breitenbach and CTO, Viktor Novy

SAN DIEGO, CA—June 26, 2019—CureMatch is pleased to announce two new hires. Katie Breitenbach has joined the AI-driven oncology treatment analysis company as chief financial officer; Viktor Novy has joined as chief technical officer. “Katie and Viktor are extremely well-regarded leaders, and a great fit for CureMatch,” said CureMatch CEO Bob Manning. “I am confident […]

Personalized Combination Therapies Yield Better Cancer Outcomes

Gratifying progress has been made recently in an emerging area of cancer medicine called precision oncology. It’s a bold attempt to target treatment to the very genes and molecules driving a cancer, aiming to slow or even halt its growth. But there’s always more to learn. Now comes evidence that, while a single well-matched drug […]

CureMatch Co-Founder Shares Findings HTLV-1 BLV Viruses Can Accelerate Development of Various Cancers

CureMatch’s co-founder and Chief Science Officer, Dr. Igor Tsigelny contributed to recently published cancer research concerning impact of viruses HTLV-1 and BLV on development of various cancers which could prove helpful to future CureMatch work. Findings are hopeful that it may be possible to eradicate these viruses acceleration of various cancers. The human T-cell leukemia […]

Wehealth by Servier and Curematch Announce Partnership to Deliver a Decision-support Digital Platform for Oncologists Worldwide

San Diego, CA (USA), Paris (France), – WeHealth by Servier, Servier Group’s e-health department, and CureMatch, a leader in digital health precision medicine announce a partnership to jointly bring the CureMatch digital platform to oncologists, clinics and hospitals around the world. We’ve been working with oncologists closely the past few years and understand they face a […]

J&J Innovation Podcast Features CureMatch’s Stephane Richard

Tune in to the J&J Innovation Podcast series featuring CureMatch’s Stephane Richard. J&J’s host, Caroline Baratz goes in depth to discover more about the people behind innovative companies ushering in the latest trends in healthcare.

Launch of CureMatch Certified Precision Oncology Recognition Award
CureMatch, a leader in precision oncology, is proud to announce the establishment of the CureMatch...
CureMatch Announces Collaboration with Mark Cuban Cost Plus Drug Company to Promote Affordable Cancer Treatment
CureMatch, Inc., a healthcare technology company using precision medicine support for oncology, is proud to...
CureMatch Joins CancerX to Help Advance Innovative Cancer Treatments
CureMatch, Inc., a healthcare technology company leveraging Knowledge Representation & Reasoning (KRR) AI for precision...
The Complex Cancer Puzzle | Video 1
CureMatch and Mprobe Partner to Help Cancer Patients Determine Optimal Treatments
CureMatch will leverage mProbe’s targeted proteomics platform to assess individual proteins within patients’ tumor tissues....
CureMatch Granted CPT® Code by American Medical Association for its Algorithmic Cancer Therapy Ranking Service
Oncologists will be able to submit claims to payers using a Category III CPT code,...
CureMatch CEO Navid Alipour named a Top 50 Honoree Leader of Influence in Life Science by San Diego Business Journal
Congratulations to CureMatch CEO Navid Alipour for being named a Top Leader of Influence in...

Press

CureMatch Hires CFO, Katie Breitenbach and CTO, Viktor Novy

Personalized Combination Therapies Yield Better Cancer Outcomes

CureMatch Co-Founder Shares Findings HTLV-1 BLV Viruses Can Accelerate Development of Various Cancers

Wehealth by Servier and Curematch Announce Partnership to Deliver a Decision-support Digital Platform for Oncologists Worldwide

J&J Innovation Podcast Features CureMatch’s Stephane Richard

Please fill out the information below and a CureMatch representative will reach out to you.

Physician Request

Get ready to utilize the latest genomics data in your practice

Rank the most promising systemic therapies for your patients

Do you need to filter out those therapies with poor outcomes

Sort through 4.5 million expertly curated combinations of drugs

Compute your own drug choices alongside CureMatch data